Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047281
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2002-10-03
Brief Title:
Thalidomide Celecoxib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
ACTUAL
Primary Completion Date:
2005-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-10-03
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-06
Last Update Post Date:
2017-07-11
Last Update Post Date Type:
ACTUAL